Figure 2.
Survival curves from EOT for patients without evidence for progression at EOT. (A) PFS stratified by monotypic PCs at 0.1% cutoff. (B) Overall survival stratified by monotypic PCs at 0.1% cutoff.
Survival curves from EOT for patients without evidence for progression at EOT. (A) PFS stratified by monotypic PCs at 0.1% cutoff. (B) Overall survival stratified by monotypic PCs at 0.1% cutoff.
